Relationship Between Markers of Platelet Activation and Inflammation with Disease Activity in Wegener’s Granulomatosis
Authors:
- Michael LavalleyMLMichael Lavalley
- Kahraman TanriverdiKTKahraman Tanriverdi
- Javier D. FinkielmanJFJavier D. Finkielman
- John C. DavisJDJohn C. Davis
- Gary S. HoffmanGHGary S. Hoffman
- W. JOSEPH McCUNEWMW. JOSEPH McCUNE
- E. William St. ClairECE. William St. Clair
- Ulrich SpecksUSUlrich Specks
- Robert SpieraRSRobert Spiera
- John H. StoneJSJohn H. Stone
- Jane E. FreedmanJFJane E. Freedman
- 16 March 2011
- journal article
- research article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 38 (6) , 1048-1054
Abstract
Objective.: There remains a need for biomarkers to guide therapy in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Our objective was to determine whether measures of platelet activation or inflammation are associated with disease activity in Wegener’s granulomatosis (WG).Methods.: Study subjects were participants in a clinical trial. Soluble CD40 ligand (sCD40L), C-reactive protein, interleukin 6 (IL-6), IL-8, monocyte chemoattractant protein 1 (MCP-1), P-selectin, vascular endothelial growth factor, and proteinase 3 (PR3)-specific ANCA were measured by ELISA using plasma samples obtained at baseline (active disease), at remission, and prior to, during, and after first flares. Disease activity was assessed by the Birmingham Vasculitis Activity Score for WG (BVAS/WG). Association of biomarkers with disease activity was determined with conditional logistic and linear regression.Results.: Over a mean followup of 27 months, 180 subjects underwent 2044 visits; markers were measured in 563 samples. Longitudinally, all markers other than IL-6 were associated with disease activity. The strongest associations for active disease at baseline versus remission were observed for sCD40L (OR 4.72, 95% CI 2.47–9.03), P-selectin (OR 6.26, 95% CI 2.78–14.10), PR3-ANCA (OR 9.41, 4.03–21.99), and inversely for MCP-1 (OR 0.36, 95% CI 0.22–0.57). BVAS/WG increased by 0.80 (95% CI 0.44–1.16), 0.83 (95% CI 0.42–1.25), and 0.81 (95% CI 0.48–1.15) per unit-increase in PR3-ANCA, sCD40L, and P-selectin, respectively; and decreased by 1.54 (95% CI 0.96–2.12) per unit-increase in MCP-1.Conclusion.: Cytokines arising from within the circulation, including those of platelet activation, correlate with disease activity in WG.Keywords
This publication has 39 references indexed in Scilit:
- Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody–associated small‐vessel vasculitis: Comparison of two independent cohortsArthritis & Rheumatism, 2008
- Damage caused by Wegener's granulomatosis and its treatment: Prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)Arthritis & Rheumatism, 2005
- Design of the Wegener's Granulomatosis Etanercept Trial (WGET)Controlled Clinical Trials, 2002
- Vascular Endothelial Growth Factor Modulates Neutrophil Transendothelial Migration via Up-regulation of Interleukin-8 in Human Brain Microvascular Endothelial CellsJournal of Biological Chemistry, 2002
- Monocyte activation in patients with Wegener's granulomatosisAnnals of the Rheumatic Diseases, 1999
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999
- Mechanisms by which oxygen regulates gene expression and cell-cell interaction in the vasculatureKidney International, 1997
- Nomenclature of Systemic VasculitidesArthritis & Rheumatism, 1994
- Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent plateletsNature, 1992
- Wegener Granulomatosis: An Analysis of 158 PatientsAnnals of Internal Medicine, 1992